Compare iShares Core Growth Allocation ETF (AOR) vs Medpace Holdings Inc (MEDP) Price & Performance

AOR, the iShares Core Growth Allocation ETF, trades at $70.11, up 0.27% on the day. Technical indicators show a bullish trend with strong moving average signals, though the RSI suggests potential overbought conditions. The ETF maintains a fixed 60/40 stock/bond allocation, rebalanced semiannually, with a low expense ratio of 0.20%.

The outlook for AOR is mixed; it offers diversified exposure and cost efficiency, but has underperformed the S&P 500 over the past decade. Key risks include market volatility and allocation strategy limitations. Analyst sentiment is generally positive for long-term core holdings.

MEDP trades at $596.98, down 0.9% on the day but near its 52-week highs. The stock shows strong technical momentum with bullish moving averages and recent golden cross formation. Fundamentally, the company delivered three consecutive quarterly earnings beats with Q2 2026 EPS of $4.25 beating expectations of $3.98. Revenue growth remains robust at 17.2% year-over-year in Q2 2026, supported by record net bookings and a $3.0 billion backlog.

MEDP presents a growth story with strong fundamentals but trades at premium valuations (P/E 35.58, P/S 6.27). The primary investment opportunity lies in continued execution on record bookings and backlog conversion. Key risks include the ongoing shareholder litigation investigation and potential valuation compression if growth moderates. Analyst consensus targets $599.57 with 21% buy ratings, suggesting limited near-term upside from current levels.